An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and “turbo cancer” in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program.
…
In his new position, [Harvey] Risch will oversee a group which is assigned to monitor “the development and execution of the activities of the National Cancer Program and report to the President on progress, efficacy, and opportunities for improvement”….
Now experts are worried that he could derail critical research into the causes and treatments for cancer.
“Having him on the panel … is a disaster for cancer patients, as he will inject conspiracy theories, pseudoscience, and false claims about cancer into the panel’s reports,” alleges Dr. David Gorski, a surgical oncologist.
Share this article
…
“I am genuinely concerned that we are going to see ivermectin for cancer promoted at the federal level,” [said another doctor speaking on the condition of anonymity]….
